MindBio Therapeutics Corp. MBQIF Archives

WednesdayJul 01, 2026 10:30 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio kiosks use artificial intelligence and voice analysis to detect potential intoxication and fatigue in workplace environments. The company is targeting industries such as mining, aviation, construction, transportation, and law enforcement, where safety-sensitive operations require large-scale screening. MindBio’s AI models have been trained on more than 50 million data points and analyze over 140 acoustic markers associated with impairment. Prototype kiosks are entering testing, validation, and data-analysis phases, before broader commercial deployment. The company is positioning this important new technology as a faster and…

FridayJun 26, 2026 2:16 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Analytics Beyond Traditional Screening

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) is a biotechnology company commercializing AI-driven voice technology for drug and alcohol intoxication detection. The company was featured in a recent article that discussed its efforts to broaden the scope of its platform with the development of a fatigue prediction model designed for high-risk workplace environments. “The fatigue detection capability is expected to become an additional feature within MindBio’s planned Edge AI Intoxication Detection Kiosks, which are being designed to identify signs of alcohol, drug impairment and fatigue from short voice…

ThursdayJun 18, 2026 1:01 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Positions AI Voice Analysis as Scalable Testing Alternative

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) was featured in a recent TechMediaWire Podcast, where CEO Justin Hanka discussed the company’s plans to commercialize AI-powered voice analysis technology designed to detect alcohol and drug intoxication through non-invasive speech assessment. During the interview, Hanka explained that the company has built prediction models using more than 50 million data points collected through years of clinical research, enabling the identification of intoxication indicators associated with alcohol and drug use. MindBio believes its technology offers a scalable alternative to traditional testing methods that…

ThursdayJun 18, 2026 9:00 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Launches Lead Commercial Software Intox AI(TM) for Multiple Forms of Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. The platform is designed to detect cocaine, cannabis, alcohol, narcotics, psychedelics, and human fatigue using voice analysis and artificial intelligence. MindBio is preparing to deploy the software through Edge AI kiosk systems targeted at safety-critical industries. The company is pursuing commercialization opportunities in mining, aviation, construction, transportation, and law enforcement markets. MindBio’s technology offers a non-invasive and affordable alternative to traditional drug and alcohol testing methods. The launch represents a key step in the company’s transition from research and clinical development toward commercial implementation.…

TuesdayJun 09, 2026 9:40 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio’s Edge AI Kiosks Use Voice and AI to detect intoxication and fatigue. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the completion and delivery of its first prototype Edge AI Intoxication Detection Kiosks, a hardware and software platform designed to detect intoxication and fatigue through AI-powered voice analysis. The kiosks are intended for workplace environments and are being developed to help improve safety across industries where drug, alcohol and fatigue monitoring are critical. The company said the prototypes will now undergo testing,…

FridayJun 05, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets Growing Need for Non-Invasive Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is developing AI-powered voice analysis technology designed to detect drug and alcohol impairment from short speech samples. The platform analyzes more than 140 acoustic markers and has been trained on a dataset exceeding 50 million data points. Mining operations in South America represent the company’s initial commercial focus, where workforce safety and high-volume screening requirements create operational challenges. Potential applications extend beyond mining into aviation, construction, law enforcement, call centers, transportation, and mental health settings. The global alcohol and drug testing devices…

ThursdayJun 04, 2026 12:55 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Launches Intox AI(TM) for Validation and Testing

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the launch of its Intox AI(TM) software platform for validation and testing. The AI-driven voice analytics solution is designed to detect intoxication and fatigue by analyzing speech patterns and is capable of identifying indicators associated with cocaine, cannabis, alcohol, psychedelics, narcotics and human fatigue. The company said the technology is intended for deployment through Edge AI kiosks currently nearing prototype manufacturing completion. MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6) (OTCQB: MBQIF) is targeting commercialization opportunities…

ThursdayMay 21, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Platform with Fatigue Detection Module

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is expanding its AI voice analytics platform to include fatigue detection alongside drug and alcohol impairment screening. MindBio filed a patent application covering detection of neurologically active substances and fatigue through voice analysis. Fatigue prediction module will be added to Edge AI Intoxication Detection Kiosks targeted at industrial workplaces. Management says commercial testing of kiosk hardware and software remains on track for late Q2 2026. The company is positioning its technology as a non-invasive alternative to breath, saliva, blood and laboratory-based testing…

TuesdayMay 19, 2026 2:26 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Advancing Workplace Safety with AI-Powered Technology

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) is introducing a novel system aimed at identifying drug and alcohol impairment, initially focused on the South American mining sector, where remote operations and heavy machinery make safety monitoring critical. An article discussing this reads, “The biotechnology company, which has spent several years conducting research into intoxication detection, has developed a voice-based AI system designed to identify signs of alcohol or drug impairment within seconds, the first of its kind in the world. Instead of relying on traditional biological testing methods…

FridayMay 15, 2026 9:00 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) CEO Highlights AI Voice Detection Platform and Workplace Rollout Plans During TechMediaWire Podcast

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. During a recent TechMediaWire Podcast appearance, Justin Hanka outlined MindBio Therapeutics’ progress in developing advanced AI-driven voice analysis technology for drug and alcohol intoxication detection. MindBio Therapeutics Corp. says its prediction models are trained using more than 50 million data points collected through years of clinical and behavioral research. The company’s initial commercial strategy focuses on workplace safety sectors including mining, aviation, and construction, where impairment-related incidents carry significant operational and regulatory risks. Hanka said during the interview that the company’s voice-analysis platform can…

Site Search

Company Search

Tag: MindBio Therapeutics Corp. MBQIF